Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Genmab A/S CPSE:GMAB |
105,16 B | 14,29% | 4/6 | -4,48% | 54,09% | 37,19% | DOWN |
|
Ascendis Pharma A/S NasdaqGS:ASND |
14,04 B | 144,29% | 4/6 | 91,21% | 89,60% | 25,11% | UP |
|
ALK-Abelló A/S CPSE:ALK B |
44,80 B | 32,62% | 5/6 | 55,34% | 25,38% | 26,11% | UP |
|
Bavarian Nordic A/S CPSE:BAVA |
14,93 B | 21,29% | 5/6 | -21,10% | 19,30% | 42,45% | DOWN |
|
BioPorto A/S CPSE:BIOPOR |
0,43 B | -11,13% | 2/4 | 0,00% | 30,54% | -100,00% | DOWN |
|
FluoGuide A/S OM:FLUO |
0,59 B | 0,00% | 2/4 | 0,00% | 0,00% | 249,58% | DOWN |
|
Evaxion A/S NasdaqCM:EVAX |
0,03 B | 0,00% | 0/0 | -47,94% | -2461,67% | 168,82% | DOWN |
|
Initiator Pharma A/S OM:INIT |
0,22 B | 0,00% | 2/4 | 0,00% | 0,00% | 202,21% | DOWN |
|
IO Biotech NasdaqGS:IOBT |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | 3533,33% | DOWN |
|
Strategic Partners A/S CPSE:STRAP |
0,03 B | 0,00% | 3/4 | 0,00% | 0,00% | -100,00% | DOWN |
|
Scandion Oncology A/S BST:8VY |
0,00 B | 0,00% | 3/4 | 0,00% | 0,00% | 0,00% | DOWN |
|
Forward Pharma A/S OTCPK:FWPA.Y |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
